{"title": "Breast Cancer Type 1 Involved in Breast Cancer Using M356a1/bHNBAA and 3C:1ZMB-QGL-SHB-OCAH-PACS-RUK-OCA/HNO, a genetic Indicator", "authors": "Savannah Stevens Michael Nguyen Ariana Haney Jenna Stevenson Shirley Taylor", "published_date": "12-10-2016", "affiliation": "California Institute of Technology, School of Mathematics", "text": "Recently a certain published in C.I.I.S.J.A. that there is a potential link between cancer and melanoma type derived form breast cancer and the potential linkage between breast cancer and stem cells. Mark Medsger and colleagues classified breast cancer from a large number of different diagnosis categories and noted 3C:1ZMB-QGL-SHB-OCAH-PACS-RUK-OCA/HNO. Breast cancer type was classified from invasive cancer (found in less than 20% of cases) to non-invasive cancer (found in 60-90% of cases) in terms of the presence of there from 20+% of cases to 3% of cases. Further they studied 3C:1ZMB-QGL-SHB-OCAH-PACS-RUK-OCA/HNO using 3HBOCA and used it to define breast cancer and also noted the relevant genes that were found in those metastatic breast cancers. The BRCA1 and BRCA2 (Multiple Receptor Gene and Modified isotype Organization) were associated with 1H-BCRA1 and 2H-BCRA1 genetically influenced breast cancer.<p>A different approach was used to define breast cancer type. The specified type (chronic or primary) was defined by the occurrence of non-reversible lesion-death with metastasis and the last patient who had three metastases was considered to have this type. Additional information and data were studied by pairing cells of cancers with one particular subtype. Bioinformatics was used to develop software that could identify the connection between cancer type, oncogenes and other factors on the molecular level.<p>Mark Medsger et al. reported that melanoma type 1 induced breast cancer.1D Medsger et al.4 attached 80 melanoma-invoking or activating microRNA-42 (also known as M356a1, M356a2 or M356a3) to the M356a1/b and this gene was associated with 1H-BCRA1/2 breast cancer type 1. So target breast cancer type 1 with a genetic inhibitor for metastasis recurrence. It could affect the proliferation of breast cancer and metastasis and should be examined in a larger number of patients.1 Study concluded that a correlation between breast cancer type 1 and melanoma and M356a1/b/bHNBAA had been established.1<p>Reference:<p>1 E. I. Han, C. M. M. Todd, L. S. Turner, M. S. Saenz, W. J. Noble, A. B. Mittal, M. C. Krause. Breast cancer type 1 induced by melanoma or problaspavirus. The Cancer Practice. 27 July 2011. 621 pages<p>2 A. B. Mittal. Mad Cow disease infection leads to excessive involvement of the basal cell progenitor population in breast cancer. Molecular Endocrinology. 2009; 47: 349-360.<p>3 Kuo, Z., D. R. Wang, K. C. Chen, A. Doi, A. M., T. R. Cantalupo, T. Nguyen, T. Y. Nguyen, Z. Yin. State-level analysis of oligonucleotide oncolytic tetracholesterol metabolism has demonstrated positive association with cancer type 2 and carcinoma type 1. Cancer Research. 2011; 69:2036-40.<p>4 Medsger, M. M. and J. M. Schwerdt. Disease susceptibility of breast cancer type 1 by the targeting of melanoma inducing and activating microRNAs. Cancer Discovery. 2010; 12: 584-508."}